Atlas Trials

CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT

Clinical trial NCT05943067 · RECRUITING

Trial details

NCT number
NCT05943067
Sponsor
University Hospital Tuebingen
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hematologic Malignancy
Start date
2023-04-27
Primary completion
2028-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.